CINCINNATI, Jan. 27, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified company focused on generating profitable revenues through license agreements and the development of a proprietary technology platform in the nano-robotics space, today announced the appointment of Mr. Jason E. Barkeloo ("Mr. Barkeloo") to the Company's Business Advisory Board. Mr. Barkeloo currently serves as Chief Executive Officer ("CEO") of Bacterial Robotics LLC ("Bacterial Robotics") and President of each of its two wholly owned subsidiaries: Auricle Solutions ("Auricle Solutions") and Pilus Energy LLC ("Pilus Energy").
The Business Advisory Board's mandate is to assist the Company with management and guidance, developing strategies for funding, improving capital structure, identifying new opportunities and technical expertise in the development of the Company's businesses. Mr. Barkeloo will specifically assist the Company in enhancing the value of Pilus Energy's global brand and the procurement of non-dilutive sources of funding.
Tauriga's CEO Seth M. Shaw stated, "The appointment of Mr. Barkeloo to Tauriga's business advisory board is of great long term value to the Company and its shareholders. Starting in 2009, he built Pilus Energy into a truly innovative technology firm that is nearly ready to address a large and fast growing global market. As Tauriga now completes the acquisition of Pilus Energy, we will consult closely with Mr. Barkeloo as the Company initiates the immensely important commercial pilot tests."
Commenting on his appointment, Mr. Barkeloo expressed, "What a great first-hand opportunity this is to watch Seth's team unlock its new and vast market potential. I am very excited about the opportunity to continue my involvement in Pilus Energy's future, post acquisition. This laser-focused team is driving smartly toward significant value creation for its shareholders. Such a front row seat to corporate financial growth comes along infrequently."
Personal BIO for Mr. Jason E. Barkeloo, MA, age 48
Jason has over twenty years of experience as a technology entrepreneur, researcher, investor, and educator. His undergraduate degree in Anthropology is from The Ohio State University. His Master's degree in Education had certifications in biological sciences and social studies from Antioch University. After a US Army career ending at the Walter Reed Army Institute of Research, Medical Research Unit, at Wright-Patterson AFB, Jason taught sciences through the Department of Defense's Troops to Teachers program.
Jason also completed the UC Berkeley Cleantech Institute.
As a patented inventor and author, Jason speaks publicly about entrepreneurship, biotechnology, human/computer interface models, rights management, and intellectual property development.
His memberships have included ACM, ACS, LES, and IEEE.
On November 25, 2013, the Company signed a definitive agreement to acquire Cincinnati, Ohio based Pilus Energy LLC ("Pilus Energy"), a developer of alternative cleantech energy platforms using proprietary microbial solutions that creates electricity while consuming polluting molecules from wastewater. Upon consummation of the proposed reverse merger, which has been unanimously ratified by Tauriga's board of directors, Pilus Energy will become a wholly owned subsidiary of Tauriga.
About Tauriga Sciences, Inc.:
Tauriga Sciences, Inc. (TAUG) is a diversified company focused on generating profitable revenues through license agreements and the development of a proprietary technology platform in the nano-robotics space. The mission of the Company is to acquire and build a diversified portfolio of cutting edge technology assets that is capital efficient and of significant value to the shareholders. The Company's business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire businesses. Management is firmly committed to building lasting shareholder value in the short, intermediate, and long terms. The Company's new corporate website can be found at (www.tauriga.com).
About Pilus Energy LLC
A developer of alternative cleantech energy solutions, Pilus Energy is developing microbial solutions that clean polluting molecules from wastewater. In the process, the technology generates electricity and produces economically important gases and chemicals. Pilus Energy licenses a low-cost, scalable electrogenic bioreactor platform and wastewater-to-value BactoBots. Pilus Energy will also derive additional revenues from carbon and renewable energy credits (REC). For more information, please visit Pilus Energy's web site, (www.pilusenergy.com).
About Bacterial Robotics LLC
A pioneer in the emerging synthetic biology industry, Bacterial Robotics is headquartered in Cincinnati, Ohio (USA). The Company specializes in identifying markets for developing and deploying BactoBots(TM) and ViruBots(TM); microscopic organism-based robots that produce, build, sense, and perform functions. These are protected through a unique anti-theft and anti-release security system known as a genetics rights management (GeRM) system. Please visit the corporate website at http://bacterialrobotics.com for more information.
Forward-Looking Statements: Except for statements of historical fact, this news release contains certain "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995, including, without limitation expectations, beliefs, plans and objectives regarding the development, use and marketability of products. Such forward-looking statements are based on present circumstances and on TAUG's predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, and are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results expressed or implied by such forward-looking statements. Such factors include general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to fund operations and other factors over which TAUG has little or no control. Such forward-looking statements are made only as of the date of this release, and TAUG assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. Readers should not place undue reliance on these forward-looking statements. Risks, uncertainties and other factors are discussed in documents filed from time to time by TAUG with the Securities and Exchange Commission. This press release does not and shall not constitute an offer to sell or the solicitation of any offer to buy any of the securities, nor shall there be any sale of the securities, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. The securities have not been registered under the Securities Act of 1933, as amended (the "Securities Act") or any state securities laws, and may not be offered or sold in the United States absent registration, or an applicable exemption from registration, under the Securities Act and applicable state securities laws.
CONTACT: Tauriga Sciences, Inc.:
Mr. Seth M. Shaw
Chairman & Chief Executive Officer
Tauriga Sciences, Inc.www.tauriga.comNew York: +1-917-796-9926
Source: Tauriga Sciences Inc